Optimize your product journey with our pharmaceutical launch services
- Distribution Strategy
- Trade Marketing
- Data Integration
- Financial Modeling
Once your product is approved, will you be ready to go to market?
For emerging pharma companies, it can be a challenge to stay on top of everything that needs to be done to bring a new drug to the market. From clinical trials to finally obtaining FDA approval, it’s an arduous process that involves a lot of moving parts.
In the midst of going through this process, it can be easy to lose sight of your product launch strategy. In many cases, the executives of emerging pharma companies have come from big pharma where they had teams of people who focused on product launch, as well as matters like compendia submissions and EHRx strategy. But now, with a much smaller team and fewer resources, they often find themselves unprepared to go to market once their drug is approved.
How We Can Help with Your Pharma Product Launch
Two Labs has supported more than 250 biopharma product launches
Two Labs’ team attentively manages the complex commercialization process from where you are to where you want to go, avoiding costly and time-consuming missteps that may delay a launch. We work together to develop a comprehensive distribution strategy, whether your product is for retail, specialty pharmacy, specialty distribution or a hybrid approach.
While it is a complex process, we go to lengths to make sure that things stay simple on our clients’ end. That’s why each of our clients is assigned a skilled account director to manage the entire launch process and a team of experts who deliver their specific knowledge and experience at crucial times in the implementation.
Specialty Launch Services
Orphan drugs, cell & gene and other specialty products have accounted for the majority of the U.S. Food & Drug Administration approvals for the past several years, and this trend is expected to continue.
That said, specialty launches tend to be more complicated than traditional retail launches.
For specialty drugs, we provide several additional services, including pharmacy network selection, therapy management program design, specialty data recommendations and analytics strategy, and more.